US2017281771A1PendingUtilityA1

Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions

55
Assignee: CYTORI THERAPEUTICS INCPriority: Dec 7, 2001Filed: Mar 17, 2017Published: Oct 5, 2017
Est. expiryDec 7, 2021(expired)· nominal 20-yr term from priority
A61K 45/06A61K 35/28C12N 5/0653A61K 2300/00
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Adipose derived regenerative cells are used to treat patients, including patients with cardiovascular conditions, diseases or disorders. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of regenerative cells, e.g., stem and/or progenitor cells, obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the stem cells are not exposed to an external environment prior to being administered to a patient. Accordingly, in a preferred method, adipose derived regenerative cells are placed directly into a recipient along with such additives necessary to promote, engender or support a therapeutic cardiovascular benefit.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for treating a disorder characterized by insufficient cardiac function in a subject, comprising administering to the subject a composition comprising adipose derived cells, such that the disorder is treated.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.